Literature DB >> 22858377

Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance.

Andrew J Vincent1, Suping Ren, Lillianne G Harris, Daniel J Devine, Rajeev S Samant, Oystein Fodstad, Lalita A Shevde.   

Abstract

The expression of Nuclear Protein 1 (NUPR1) is associated with chemoresistance in multiple malignancies. We previously reported that NUPR1 functions as a transcriptional cofactor for the p300-p53 complex and transcriptionally regulates p21 expression. In the present study we investigated the activity of NUPR1 in p53-deficient, triple-negative, inflammatory SUM159 breast cancer cells. Our studies reveal that NUPR1 confers growth benefit and chemoresistance by causing Akt-mediated phosphorylation and subsequent cytoplasmic re-localization of p21 and activation of the anti-apoptotic Bcl-xL protein. Our findings elucidate a NUPR1-PI-3-K/Akt-phospho-p21 axis that functions in p53-negative, inflammatory breast cancer cells to enhance chemoresistance in breast cancer.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858377     DOI: 10.1016/j.febslet.2012.07.063

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  23 in total

1.  NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells.

Authors:  Yanchao Mu; Xiaojie Yan; Ding Li; Dan Zhao; Lingling Wang; Xiaoyang Wang; Dan Gao; Jie Yang; Hua Zhang; Yanzhe Li; Yanan Sun; Yiliang Wei; Zhenfa Zhang; Xinzhong Chang; Zhi Yao; Shanshan Tian; Kai Zhang; Lance S Terada; Zhenyi Ma; Zhe Liu
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

2.  Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project.

Authors:  Bo Hwa Sohn; Jun-Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Sang Cheul Oh; Jae-Jun Shim; Keun-Wook Lee; Eui Hyun Kim; Sun Young Yim; Sang Ho Lee; Jae-Ho Cheong; Woojin Jeong; Jae Yong Cho; Joohee Kim; Jungsoo Chae; Jeeyun Lee; Won Ki Kang; Sung Kim; Sung Hoon Noh; Jaffer A Ajani; Ju-Seog Lee
Journal:  Clin Cancer Res       Date:  2017-07-26       Impact factor: 12.531

3.  Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study.

Authors:  Nilda E Real; Gisela N Castro; F Darío Cuello-Carrión; Claudia Perinetti; Hanna Röhrich; Niubys Cayado-Gutiérrez; Martin E Guerrero-Gimenez; Daniel R Ciocca
Journal:  Cell Stress Chaperones       Date:  2017-06-12       Impact factor: 3.667

4.  Molecular insight into thiopurine resistance: transcriptomic signature in lymphoblastoid cell lines.

Authors:  Laurent Chouchana; Ana Aurora Fernández-Ramos; Florent Dumont; Catherine Marchetti; Irène Ceballos-Picot; Philippe Beaune; David Gurwitz; Marie-Anne Loriot
Journal:  Genome Med       Date:  2015-04-18       Impact factor: 11.117

5.  Altering cancer transcriptomes using epigenomic inhibitors.

Authors:  Malaina Gaddis; Diana Gerrard; Seth Frietze; Peggy J Farnham
Journal:  Epigenetics Chromatin       Date:  2015-02-24       Impact factor: 4.954

6.  Cytoplasmic localization of p21 protects trophoblast giant cells from DNA damage induced apoptosis.

Authors:  Christelle de Renty; Melvin L DePamphilis; Zakir Ullah
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

7.  Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney.

Authors:  Giovanni Corsetti; Giuseppe D'Antona; Chiara Ruocco; Alessandra Stacchiotti; Claudia Romano; Laura Tedesco; Francesco Dioguardi; Rita Rezzani; Enzo Nisoli
Journal:  Amino Acids       Date:  2014-06-13       Impact factor: 3.520

8.  PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents.

Authors:  Makoto Nakakido; Zhenzhong Deng; Takehiro Suzuki; Naoshi Dohmae; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Oncotarget       Date:  2015-10-13

Review 9.  Nuclear protein 1 imparts oncogenic potential and chemotherapeutic resistance in cancer.

Authors:  Anthony Murphy; Max Costa
Journal:  Cancer Lett       Date:  2020-08-22       Impact factor: 8.679

10.  Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.

Authors:  Nina-Naomi Kreis; Frank Louwen; Brigitte Zimmer; Juping Yuan
Journal:  Oncotarget       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.